Optimizing the Implementation of Tobacco Treatment for People with HIV: A Pilot Study

Madeline G. Foster, Benjamin A. Toll, Emily Ware, Allison Ross Eckard, Katherine R. Sterba and Alana M. Rojewski ()
Additional contact information
Madeline G. Foster: Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC 29425, USA
Benjamin A. Toll: Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC 29425, USA
Emily Ware: Clinical Pharmacy, Medical University of South Carolina, Charleston, SC 29425, USA
Allison Ross Eckard: Departments of Pediatrics and Medicine, Divisions of Infectious Diseases, Medical University of South Carolina, Charleston, SC 29425, USA
Katherine R. Sterba: Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC 29425, USA
Alana M. Rojewski: Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC 29425, USA

IJERPH, 2022, vol. 19, issue 19, 1-7

Abstract: People with HIV (PWH) have higher rates of tobacco use compared to their societal counterparts and are disproportionately affected by tobacco-related morbidity and mortality. A needs assessment was conducted to assess provider beliefs and opinions on tobacco treatment barriers and treatment approaches. The results highlighted a disconnect between the known importance of quitting smoking and barriers in linking patients to treatment, such as lack of patient interest and other patient issues being a higher priority. Using this assessment data, a treatment delivery approach, Proactive Outreach with Medication Opt-out for Tobacco Treatment Engagement (PrOMOTE), was devised and piloted. PrOMOTE consisted of an outpatient clinical pharmacist trained in tobacco treatment proactively contacting patients for counseling and to prescribe smoking cessation pharmacotherapy (varenicline or dual nicotine replacement therapy (NRT)) using an opt-out approach. The pilot was conducted with 10 PWH and patient reach and opt-out rates were evaluated. Of the 10 patients contacted, 7 were reached and none opted out of the pharmacotherapy prescription (varenicline = 6; NRT = 1). Providers know the importance of smoking cessation for PWH but encounter several barriers to implementing treatment. Using PrOMOTE methods to deliver tobacco treatment increased the reach and pharmacotherapy acceptance rate of PWH who smoke.

Keywords: smoking cessation; tobacco treatment; implementation; HIV/AIDS (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/19/12896/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/19/12896/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:19:p:12896-:d:936524

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().